361 related articles for article (PubMed ID: 27548152)
21. A new class of cubic SPIONs as a dual-mode T1 and T2 contrast agent for MRI.
Alipour A; Soran-Erdem Z; Utkur M; Sharma VK; Algin O; Saritas EU; Demir HV
Magn Reson Imaging; 2018 Jun; 49():16-24. PubMed ID: 28958878
[TBL] [Abstract][Full Text] [Related]
22. One-pot synthesis of water-soluble superparamagnetic iron oxide nanoparticles and their MRI contrast effects in the mouse brains.
Wang J; Zhang B; Wang L; Wang M; Gao F
Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():416-23. PubMed ID: 25579942
[TBL] [Abstract][Full Text] [Related]
23. Polymeric liposomes-coated superparamagnetic iron oxide nanoparticles as contrast agent for targeted magnetic resonance imaging of cancer cells.
Liao Z; Wang H; Lv R; Zhao P; Sun X; Wang S; Su W; Niu R; Chang J
Langmuir; 2011 Mar; 27(6):3100-5. PubMed ID: 21341768
[TBL] [Abstract][Full Text] [Related]
24. Biodistribution and Toxicity Assessment of Superparamagnetic Iron Oxide Nanoparticles In Vitro and In Vivo.
Yu Q; Xiong XQ; Zhao L; Xu TT; Bi H; Fu R; Wang QH
Curr Med Sci; 2018 Dec; 38(6):1096-1102. PubMed ID: 30536075
[TBL] [Abstract][Full Text] [Related]
25. Amino-polyvinyl alcohol coated superparamagnetic iron oxide nanoparticles are suitable for monitoring of human mesenchymal stromal cells in vivo.
Schulze F; Dienelt A; Geissler S; Zaslansky P; Schoon J; Henzler K; Guttmann P; Gramoun A; Crowe LA; Maurizi L; Vallée JP; Hofmann H; Duda GN; Ode A
Small; 2014 Nov; 10(21):4340-51. PubMed ID: 24990430
[TBL] [Abstract][Full Text] [Related]
26. Highly efficient magnetic stem cell labeling with citrate-coated superparamagnetic iron oxide nanoparticles for MRI tracking.
Andreas K; Georgieva R; Ladwig M; Mueller S; Notter M; Sittinger M; Ringe J
Biomaterials; 2012 Jun; 33(18):4515-25. PubMed ID: 22445482
[TBL] [Abstract][Full Text] [Related]
27. Differential effect of polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles on BT-474 human breast cancer cell viability.
Aliakbari M; Mohammadian E; Esmaeili A; Pahlevanneshan Z
Toxicol In Vitro; 2019 Feb; 54():114-122. PubMed ID: 30266435
[TBL] [Abstract][Full Text] [Related]
28. Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation.
Neuwelt A; Sidhu N; Hu CA; Mlady G; Eberhardt SC; Sillerud LO
AJR Am J Roentgenol; 2015 Mar; 204(3):W302-13. PubMed ID: 25714316
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibody-conjugated superparamagnetic iron oxide nanoparticles for imaging of epidermal growth factor receptor-targeted cells and gliomas.
Mu K; Zhang S; Ai T; Jiang J; Yao Y; Jiang L; Zhou Q; Xiang H; Zhu Y; Yang X; Zhu W
Mol Imaging; 2015; 14():. PubMed ID: 26044549
[TBL] [Abstract][Full Text] [Related]
30. Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques.
von Zur Muhlen C; von Elverfeldt D; Bassler N; Neudorfer I; Steitz B; Petri-Fink A; Hofmann H; Bode C; Peter K
Atherosclerosis; 2007 Jul; 193(1):102-11. PubMed ID: 16997307
[TBL] [Abstract][Full Text] [Related]
31. Superparamagnetic iron oxide nanoparticle uptake alters M2 macrophage phenotype, iron metabolism, migration and invasion.
Rojas JM; Sanz-Ortega L; Mulens-Arias V; Gutiérrez L; Pérez-Yagüe S; Barber DF
Nanomedicine; 2016 May; 12(4):1127-1138. PubMed ID: 26733263
[TBL] [Abstract][Full Text] [Related]
32. CD40-targeting magnetic nanoparticles for MRI/optical dual-modality molecular imaging of vulnerable atherosclerotic plaques.
Wu Q; Pan W; Wu G; Wu F; Guo Y; Zhang X
Atherosclerosis; 2023 Mar; 369():17-26. PubMed ID: 36863196
[TBL] [Abstract][Full Text] [Related]
33. The labeling of stem cells by superparamagnetic iron oxide nanoparticles modified with PEG/PVP or PEG/PEI.
Yang G; Ma W; Zhang B; Xie Q
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():384-90. PubMed ID: 26952437
[TBL] [Abstract][Full Text] [Related]
34. Preliminary Study of MR and Fluorescence Dual-mode Imaging: Combined Macrophage-Targeted and Superparamagnetic Polymeric Micelles.
Li WJ; Wang Y; Liu Y; Wu T; Cai WL; Shuai XT; Hong GB
Int J Med Sci; 2018; 15(2):129-141. PubMed ID: 29333097
[No Abstract] [Full Text] [Related]
35. For Better or Worse, Iron Overload by Superparamagnetic Iron Oxide Nanoparticles as a MRI Contrast Agent for Chronic Liver Diseases.
Zhou Q; Wei Y
Chem Res Toxicol; 2017 Jan; 30(1):73-80. PubMed ID: 28092939
[TBL] [Abstract][Full Text] [Related]
36. Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.
Hu F; Jia Q; Li Y; Gao M
Nanotechnology; 2011 Jun; 22(24):245604. PubMed ID: 21508500
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and characterization of Bombesin-superparamagnetic iron oxide nanoparticles as a targeted contrast agent for imaging of breast cancer using MRI.
Jafari A; Salouti M; Shayesteh SF; Heidari Z; Rajabi AB; Boustani K; Nahardani A
Nanotechnology; 2015 Feb; 26(7):075101. PubMed ID: 25642737
[TBL] [Abstract][Full Text] [Related]
38. Potential use of superparamagnetic iron oxide nanoparticles for in vitro and in vivo bioimaging of human myoblasts.
Wierzbinski KR; Szymanski T; Rozwadowska N; Rybka JD; Zimna A; Zalewski T; Nowicka-Bauer K; Malcher A; Nowaczyk M; Krupinski M; Fiedorowicz M; Bogorodzki P; Grieb P; Giersig M; Kurpisz MK
Sci Rep; 2018 Feb; 8(1):3682. PubMed ID: 29487326
[TBL] [Abstract][Full Text] [Related]
39. Triple Therapy of HER2
Zolata H; Afarideh H; Davani FA
Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of pseudopolyrotaxanes-coated Superparamagnetic Iron Oxide Nanoparticles as new MRI contrast agent.
Hosseini F; Panahifar A; Adeli M; Amiri H; Lascialfari A; Orsini F; Doschak MR; Mahmoudi M
Colloids Surf B Biointerfaces; 2013 Mar; 103():652-7. PubMed ID: 23199519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
